+1-206-701-6702
+44-020-8133-4027
+81-50-5539-1737
+91-848-285-0837
Intraocular Lens Market – Global Industry Insights
Intraocular Lens (IOL) implantation enables restoration of normal vision and significantly reduces problems associated with cataract spectacles and contact lenses. Surgical techniques for extracting the human lens continued over time by means of incision size. In later days, invention of implantable, tolerable and technically feasible IOL was revolutionized in cataract surgery. In case of IOL material, Rigid or Polymethylmethacrylate (PMMA) was preferred intraocular lens material for a long time due to its lightness, clarity and stability, which were un-foldable lenses. Advancement in IOL material, PMMA are eventually replaced by silicone lens, hydrophilic and hydrophobic acrylic lenses. Moreover, continuous development in new intraocular lens (IOL) material and design has offered more options such as hydrogel, soft acrylic and silicone IOL. However, ease of use, availability, cost, and surgeon preference are also important factors, which influence IOL selection. Currently, key players in the intraocular lens market offers various types IOLs to improve the vision, which includes monofocal lens, multifocal lens, toric lens, accommodating lens, and trifocal lens.
Increasing numbers of cataract surgeries, coupled with growing demand for multi-distance vision lens and significant increase in awareness programs for cataract patients by various government and private organizations are expected to augment growth of the intraocular lens market over the forecast period. Moreover, adoption of advanced technologies in cataract surgery and entry of various market players offering technologically advanced intraocular lens with affordable costs are further expected to drive growth of intraocular lens market. For instance, several market players in Asia are offering products with comparable performance levels to that of high-end intraocular lens, albeit at affordable costs. The intraocular lens market is expected to exhibit rapid growth in Asian economies such as China and India. This is mainly attributed to factors such as increasing availability of skilled physicians and healthcare practitioners, lower costs incurred with medical facilities and combined efforts of government and domestic players to increase patient access.
The global intraocular lens market was valued at US$ 3.8 billion in 2017 and is expected to witness a CAGR of 7.5% over the forecast period (2017 – 2025).
Global Intraocular Lens Market Share, By Flexibility
Increasing number of Cataract Surgeries is expected to Drive Growth of the Intraocular Lens Market
Diabetes, prolonged exposure to sunlight, consumption of tobacco and alcohol are the major factors causing cataract and rising number of cataract patients increasing the demand for cataract surgeries. In addition to this, rising diabetes patients has led to increase in number of cataract surgery, as diabetes is a major cause of blindness. According to World Health Organization (WHO), around 422 million people were suffering from diabetes in 2014. Moreover, according to WHO in 2017, an estimated 253 million people were suffering from vision impairment, out of which around 36 million population was blind and 217 million had moderate to severe vision impairment. The cataract is a major cause of blindness in America, as it is related to the aging process. According to WHO in 2017, occurrence of cataract globally is 46%, which supports the growth of intraocular lens market.
Increasing Governmental Initiatives and Awareness Programs for Cataract Patients is Driving Growth of the Intraocular Lens Market
Governmental and non-governmental organization are working together to spread awareness regarding cataract and associated conditions such as blindness. For instance, according to WHO in 2017, an estimated 253 million people had vision impairment worldwide, which creates the need for government to take initiatives and conduct awareness program for cataract patients. WHO and Task Force of International NGO have jointly prepared and launched a common agenda for global action called ‘The Vision 2020- the right to sight’ in 1999 with aim to eliminate blindness worldwide by 2020. This organization works jointly to mitigate implications of blindness in developmental, economic, social and quality of life terms, which is expected to augment the growth of intraocular lens market in near future. Furthermore, International Agency for the Prevention of Blindness, Al Noor Foundation, Christoffel-Blindenmission (Christian Blind Mission International), Helen Keller Worldwide, International Federation of Ophthalmological Societies, Lions Clubs International Foundation, Organization pour la Prévention de la Cécité, Operation Eyesight Universal, ORBIS International, Sight Savers International, The Carter Center, and The Fred Hollows Foundation are other NGOs participating in the Vision 2020 program to prevent blindness worldwide. In India, as a part of initiative launched by Maharashtra Government, around 1,700,000 cataract patients are likely to undergo the cataract surgeries between December 2017 and July 2019, supporting increasing demand for intraocular lens for cataract patients. In 2011, Lions Clubs International Foundation (LCIF) in partnership with Peoples Republic of China initiated a new phase of their campaign in China called as SightFirst China Action (SFCA), which aims at preventing blindness.
However, over pricing of intraocular lens and stringent regulations in getting premarket approval for intraocular lens is expected to restrain growth of intraocular lens market over the forecast period. For instance, the Maharashtra Food and Drug Administration (FDA), India in 2017 revealed the overpricing of intraocular lenses, which stated that the patients undergoing cataract surgeries are priced at least 200% to 300% higher than the purchase cost.
Major players operating in market include STAAR Surgical Company, HOYA Corporation, Lenstec, Inc., Ophtec BV, Johnson & Johnson, Alcon, Bausch & Lomb Incorporated, Carl Zeiss Meditec AG, Rayner Intraocular Lenses Limited, and HumanOptics AG.
Intraocular lens (IOLs) are medical devices implanted inside the eye to replace natural lens when it is removed during cataract surgery. Intraocular lens area also used during few vision correction surgery. Depending on patient’s visual need and lifestyle; wide variety of intraocular lens are present in the market, including aspheric IOLs, toric IOLs, multifocal IOLs, monofocal IOLs, accommodating IOLs, preloaded IOLs, and among others. Moreover, depending on need during cataract surgery and in order to get recommended results; surgeons can mix two different multifocal lens or two different types of intraocular lenses. Increasing government initiatives and awareness programs for cataract patient with aim to eliminate blindness, coupled with growing prevalence of cataract surgeries and introduction of new affordable intraocular lens by various key players are expected to drive growth of the intraocular lens market over the forecast period. Furthermore, significant increase in aging population, high prevalence of diabetes, exposure to ultraviolet sunlight, and family history are the factors contributing to the growth of the global market. For instance, according to American Diabetes Association (ADA) in 2015, around 30.3 million Americans or 9.4% of the population had diabetes, which are likely to develop glaucoma and cataract.
Market Dynamics
The increasing government initiatives and awareness campaign to spread the awareness among cataract patients and the increasing prevalence of diabetes may shift the patient towards the cataract surgery, in turn boosting growth of the intraocular lens market during the forecast period. For instance, according to the International Diabetes Foundation (IDF) 2017 statistics, the number of people with diabetes aged between 20 to 79 years are increasing, globally. Among which, Africa (156%) is accounted to register the highest diabetic population, followed by Middle East (110%), South East Asia (84%), Latin and Central America(62%), North America (35%), Europe (16%) and Western Pacific (15%). Moreover, cataract is major cause of blindness, which is projected to fuel growth of the intraocular lens market over the forecast period. For instance, according to National Federation of the Blind, 2014 data findings, an estimated around 10 million people in the U.S. are blind or visually impaired. According to European Blind Union, in 2016, over 30 million people are partially sighted or blind in Europe and an average of 1 in 30 Europeans experience sight loss. According to World Health Organization (WHO) 2010 fact sheet, cataract accounted for around 50% of blindness in China. Furthermore, according to National Center for Biotechnology Information (NCBI), 2010 data findings, an estimated 11.2 million people above age 40 years suffered from glaucoma in India.
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Contact Us
